<DOC>
	<DOCNO>NCT01360944</DOCNO>
	<brief_summary>The aim exploratory study compare dose-related efficacy LAS41004 Psoriasis Plaque Test ( PPT ) .</brief_summary>
	<brief_title>Exploratory Study Investigate Efficacy LAS41004 Psoriasis Plaque Test</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Key Male female patient 18 75 year age diagnosis stable plaquetype psoriasis ( psoriasis vulgaris ) least 12 month Psoriatic plaque suitable define target area lesion follow criterion : oPsoriatic plaque must locate trunk and/or extremity . Plaques locate head ( incl . scalp ) , palm , sole foot , intertriginous genitoanal area suitable target area Comparable psoriatic plaque least `` 2 '' score ( range 04 ) three distinct sign : scaling , erythema induration No 3 point difference total score ( = sum score scale , erythema induration ; Range 012 ) choose comparable psoriatic plaque Enough surface area psoriatic plaque define eight clearly distinguishable ( minimum distance test area : 1cm ) test area least 1 cmÂ² size Effective contraceptive method duration study 4 week study drug discontinuation , patient childbearing potential . Key Too small body surface area cover psoriasis plaque meet specified inclusion criterion Any condition may interfere study assessment ultrasound measurement skin and/or may influence skin immune response ( incl . open wound ) Current diagnosis guttate , erythrodermic pustular psoriasis Patients receive topical antipsoriatic drug test area within last 2 week treatment IMP . Patients receive topical product test area contain DEET ( N , Ndiethylmpolyamide ) , common component insect repellent product within 1 week treatment IMP . Patients receive systemic biologics within last 6 month treatment IMP systemic antipsoriatic treatment ( corticosteroid , ciclosporin , methotrexate , fumaric acid ester , acitretin etc ) within last 3 month treatment IMP . Significant skin disease plaquetype psoriasis ( psoriasis vulgaris ) , include limited : skin disease due tuberculosis syphilis , rosacea , perioral dermatitis , acne vulgaris , skin atrophy , stria distensae , increase fragility skin blood vessel , ichthyosis , ulcer , wound reaction vaccination Significant skin infection ( include limit : herpes , varicella , mycotic skin infection , bacterial skin infection parasitic skin infection ) Excessive sunlight exposure within 28 day prior study entry conduct study Usage topical formulation ( incl . cosmetic , emollient , etc ) designate target area course study Vitamin A intake &gt; 15,000 IU/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>PPT , topical , psoriasis</keyword>
</DOC>